Key result
Concomitant tricuspid annuloplasty during MVR linked to lower TR progression without significant TR development.
Why the study?
The benefits of concomitant tricuspid annuloplasty for trivial or mild functional tricuspid regurgitation during mitral valve replacement remain controversial.
Does concomitant tricuspid ring annuloplasty prevent significant TR aggravation in patients with trivial or mild functional TR undergoing mitral valve replacement?
Cohort (n=256)
Does concomitant tricuspid ring annuloplasty prevent significant TR aggravation in patients with trivial or mild functional TR undergoing mitral valve replacement?
Concomitant tricuspid ring annuloplasty during mitral valve replacement in patients with trivial or mild functional TR safely prevents long-term TR aggravation.
Answers are grounded in this paper and cite their sources.
May support concomitant annuloplasty in MVR with mild TR; hypothesis-generating and requires RCT confirmation before practice change.
OBJECTIVES: The benefits of concomitant tricuspid annuloplasty (TAP) for non-significant functional tricuspid regurgitation (TR) during mitral valve replacement (MVR) are controversial. We evaluated the long-term outcomes-particularly the long-term tricuspid valve (TV) functional outcomes-of MVR with or without tricuspid ring annuloplasty. METHODS: From 2004 to 2014, 256 patients (56.4 ± 12.1 years) with trivial or mild functional TR who underwent MVR were enrolled. Eighty-two patients underwent concomitant tricuspid ring annuloplasty (TAP group), and 174 patients did not undergo the TV procedure (nTAP group). Propensity score-matched analysis was performed (n = 72 in each group). The follow-up duration was 77.4 ± 42.4 months. RESULTS: The early clinical outcomes were similar between the 2 groups before and after propensity score matching with an early mortality rate of 3.5% (9 of 256). No patients experienced ring-related complications during follow-up. Eleven (6.3%) patients developed significant TR (≥moderate) in the nTAP group, while no patients developed significant TR in the TAP group. There were no significant differences in overall survival between the 2 groups before or after matching. However, propensity score-matched analysis revealed that the freedom from significant TR aggravation and freedom from TV-related event rates were significantly higher in the TAP group than in the nTAP group (P = 0.047 and P = 0.043, respectively). CONCLUSIONS: Patients with untreated trivial or mild functional TR accompanied by mitral valve disease can develop significant TR during follow-up. TV ring annuloplasty can be performed without complications and can be beneficial for patients with trivial or mild functional TR who are undergoing MVR.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2017) conducted a cohort in Trivial or mild functional tricuspid regurgitation during mitral valve replacement (n=256). Concomitant tricuspid ring annuloplasty vs. No tricuspid valve procedure was evaluated on Development of significant tricuspid regurgitation (≥moderate) (p=0.047). Concomitant tricuspid ring annuloplasty during mitral valve replacement prevented significant TR aggravation and improved freedom from TV-related events.
Synapse has enriched 10 related papers. Consider them for comparative context: